Bone Therapeutics publie ses résultats annuels 2020
29 avr. 2021 01h00 HE
|
Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Fortes avancées cliniques sur l’ensemble du portefeuille de produits, dont les essais cliniques de Phase IIb et III Mise en place de nouvelles collaborations et...
Gran Colombia Gold Reports Fourth Quarter and Full Year 2020 Results; Provides Annual Update to Segovia’s Mineral Resource and Reserve Estimates
31 mars 2021 19h39 HE
|
Gran Colombia Gold
TORONTO, March 31, 2021 (GLOBE NEWSWIRE) -- Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today the release of its audited consolidated financial statements and accompanying...
MICT, Inc. Reports Fourth Quarter 2020 and Full Year Results
31 mars 2021 08h00 HE
|
MICT, Inc.
MONTVALE, N.J., March 31, 2021 (GLOBE NEWSWIRE) -- MICT, Inc. (Nasdaq: MICT), (the "Company"), today announced its financial results for the fourth quarter and full year ended December 31, 2020. ...
Surna Reports Q4 2020 and Full Year Results
24 mars 2021 06h40 HE
|
Surna Inc
Announces $7.9 million in New Sales Contracts in second half of year, highest in Company history and 36% higher than 2019 Boulder, Colorado, March 24, 2021 (GLOBE NEWSWIRE) -- Surna Inc....
Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille pour l'année 2020
18 mars 2021 02h00 HE
|
INNATE PHARMA
Marseille, 18 mars 2021 (GLOBE NEWSWIRE) -- Lacutamab a reçu le statut « PRIME » de l’Agence Européenne du Médicament dans le syndrome de Sézary ; le programme de développement clinique avance dans...
Innate Pharma reports Full Year 2020 financial results and business update
18 mars 2021 02h00 HE
|
INNATE PHARMA
Marseille, March 18, 2021 (GLOBE NEWSWIRE) -- Lacutamab received PRIME designation from the European Medicines Agency in Sezary Syndrome; clinical development program advances in mycosis fungoides...
Arcadis reports fourth quarter and full year results 2020
18 févr. 2021 01h00 HE
|
Arcadis N.V.
Arcadis reports strong operational performance and excellent free cash flow Achieved all key strategic targets for 2020Demonstrated resilience during challenging social-economic...
Clariant delivers robust performance in 2020, successfully mitigating COVID-19 pandemic impacts
11 févr. 2021 01h00 HE
|
Clariant AG
Sales from continuing operations decreased by 5 % in local currency to CHF 3.860 billion EBITDA margin preserved at 15.0 % in a challenging environment compared to a comparable EBITDA margin of 15.7 %...
OptimumBank Holdings, Inc. (OPHC-NASDAQ) Announces
05 févr. 2021 09h00 HE
|
Optimum Bank Holdings, Inc.
Full Year Results for OptimumBank (the “Bank”) Fort Lauderdale, FL., Feb. 05, 2021 (GLOBE NEWSWIRE) -- OptimumBank Holdings, Inc. (OPHC-NASDAQ) Recap of Results: OptimumBank (the “Bank”)...
Peapack-Gladstone Financial Corporation Reports Fourth Quarter and Full Year Results and Announces a 5% Stock Repurchase Program
01 févr. 2021 09h00 HE
|
Peapack-Gladstone Financial Corporation
BEDMINSTER, NJ, Feb. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) (the “Company”) announces its fourth quarter and full...